| Terrye Mastin, APRN,BC | |
|
5625 Poplar Ave, Memphis, TN 38119-3816 | |
| (901) 761-1220 | |
| (901) 763-4332 |
| Full Name | Terrye Mastin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 37 Years |
| Location | 5625 Poplar Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730110693 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | APN6208 (Tennessee) | Secondary |
| 364SA2200X | Clinical Nurse Specialist - Adult Health | TN6208 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Cordova, TN | Home health agency |
| Baptist Memorial Hospital | Memphis, TN | Hospital |
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midsouth Independent Group Pllc | 2668886722 | 9 |
News Archive
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Qualitative data were collected in a study on infant and young child feeding in rural Benin in May 2013. This research aimed to improve understanding of complementary feeding practices of young children. It was conducted in the preparatory phase of the Work Package 4 in the FoodAfrica Programme.
A vision is to implant nerve precursor cells in the diseased brains of patients with Parkinson's and Huntington's diseases, whereby these cells are to assume the function of the cells that have died off.
People with erosive osteoarthritis of the hand are more likely to experience pain if they have also diabetes, suggests research presented at the recent annual meeting of the European League Against Rheumatism in Paris, France.
A researcher at Oregon State University has invented a way to use spent nuclear fuel to produce the gamma rays needed to irradiate medical supplies, food and other products - an advance that could change what is now a costly waste disposal concern into a valued commodity.
› Verified 3 days ago
| Entity Name | Shea Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568427128 PECOS PAC ID: 3971525635 Enrollment ID: O20090429000705 |
News Archive
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Qualitative data were collected in a study on infant and young child feeding in rural Benin in May 2013. This research aimed to improve understanding of complementary feeding practices of young children. It was conducted in the preparatory phase of the Work Package 4 in the FoodAfrica Programme.
A vision is to implant nerve precursor cells in the diseased brains of patients with Parkinson's and Huntington's diseases, whereby these cells are to assume the function of the cells that have died off.
People with erosive osteoarthritis of the hand are more likely to experience pain if they have also diabetes, suggests research presented at the recent annual meeting of the European League Against Rheumatism in Paris, France.
A researcher at Oregon State University has invented a way to use spent nuclear fuel to produce the gamma rays needed to irradiate medical supplies, food and other products - an advance that could change what is now a costly waste disposal concern into a valued commodity.
› Verified 3 days ago
| Entity Name | Rx Management Systems |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215161195 PECOS PAC ID: 5092945576 Enrollment ID: O20160130000127 |
News Archive
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Qualitative data were collected in a study on infant and young child feeding in rural Benin in May 2013. This research aimed to improve understanding of complementary feeding practices of young children. It was conducted in the preparatory phase of the Work Package 4 in the FoodAfrica Programme.
A vision is to implant nerve precursor cells in the diseased brains of patients with Parkinson's and Huntington's diseases, whereby these cells are to assume the function of the cells that have died off.
People with erosive osteoarthritis of the hand are more likely to experience pain if they have also diabetes, suggests research presented at the recent annual meeting of the European League Against Rheumatism in Paris, France.
A researcher at Oregon State University has invented a way to use spent nuclear fuel to produce the gamma rays needed to irradiate medical supplies, food and other products - an advance that could change what is now a costly waste disposal concern into a valued commodity.
› Verified 3 days ago
| Entity Name | Midsouth Independent Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861009326 PECOS PAC ID: 2668886722 Enrollment ID: O20210201001564 |
News Archive
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Qualitative data were collected in a study on infant and young child feeding in rural Benin in May 2013. This research aimed to improve understanding of complementary feeding practices of young children. It was conducted in the preparatory phase of the Work Package 4 in the FoodAfrica Programme.
A vision is to implant nerve precursor cells in the diseased brains of patients with Parkinson's and Huntington's diseases, whereby these cells are to assume the function of the cells that have died off.
People with erosive osteoarthritis of the hand are more likely to experience pain if they have also diabetes, suggests research presented at the recent annual meeting of the European League Against Rheumatism in Paris, France.
A researcher at Oregon State University has invented a way to use spent nuclear fuel to produce the gamma rays needed to irradiate medical supplies, food and other products - an advance that could change what is now a costly waste disposal concern into a valued commodity.
› Verified 3 days ago
| Entity Name | Honeycomb Medical Group Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548971450 PECOS PAC ID: 2668837204 Enrollment ID: O20230505001082 |
News Archive
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Qualitative data were collected in a study on infant and young child feeding in rural Benin in May 2013. This research aimed to improve understanding of complementary feeding practices of young children. It was conducted in the preparatory phase of the Work Package 4 in the FoodAfrica Programme.
A vision is to implant nerve precursor cells in the diseased brains of patients with Parkinson's and Huntington's diseases, whereby these cells are to assume the function of the cells that have died off.
People with erosive osteoarthritis of the hand are more likely to experience pain if they have also diabetes, suggests research presented at the recent annual meeting of the European League Against Rheumatism in Paris, France.
A researcher at Oregon State University has invented a way to use spent nuclear fuel to produce the gamma rays needed to irradiate medical supplies, food and other products - an advance that could change what is now a costly waste disposal concern into a valued commodity.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Terrye Mastin, APRN,BC 5625 Poplar Ave, Memphis, TN 38119-3816 Ph: (901) 761-1220 | Terrye Mastin, APRN,BC 5625 Poplar Ave, Memphis, TN 38119-3816 Ph: (901) 761-1220 |
News Archive
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Qualitative data were collected in a study on infant and young child feeding in rural Benin in May 2013. This research aimed to improve understanding of complementary feeding practices of young children. It was conducted in the preparatory phase of the Work Package 4 in the FoodAfrica Programme.
A vision is to implant nerve precursor cells in the diseased brains of patients with Parkinson's and Huntington's diseases, whereby these cells are to assume the function of the cells that have died off.
People with erosive osteoarthritis of the hand are more likely to experience pain if they have also diabetes, suggests research presented at the recent annual meeting of the European League Against Rheumatism in Paris, France.
A researcher at Oregon State University has invented a way to use spent nuclear fuel to produce the gamma rays needed to irradiate medical supplies, food and other products - an advance that could change what is now a costly waste disposal concern into a valued commodity.
› Verified 3 days ago